Table 1.
The sociodemographic variables, MET categories, PHQ-9, GAD-7 scores, and categories of the population
| Variables | N = 422 |
|---|---|
| Age, years | 45±12.7 |
| Women/Men, n | 350/72 |
| Education status, n (%) | 153 (37.1) |
| Primary | 46 (11.2) |
| Middle | 106 (25.7) |
| High school | 76 (18.4) |
| University | 13 (3.2) |
| College student | 11 (2.7) |
| Postgraduate | 7 (1.7) |
| Marital status, n (%) | |
| Married | 289 (69.6) |
| Never married | 85 (20.5) |
| Divorced | 25 (6) |
| Single | 16 (3.9) |
| Duration of obesity, years | 7.3±7.7 (0.02–45) |
| Physician visits, n (%) | |
| Regularly | 241 (57.1) |
| Sometimes or rarely | 145 (34.4) |
| Never | 36 (8.5) |
| Therapy for obesity, n (%) | |
| Diet | 68 (16.7) |
| Exercise | 4 (1.0) |
| Medications | 18 (4.4) |
| Diet + exercise | 99 (24.3) |
| Diet + exercise + behavioral therapy | 33 (6.1) |
| Diet + exercise + medications | 82 (20.1) |
| Bariatric surgery | 104 (25.5) |
| Complications, n (%) | |
| DM | 174 (41.2) |
| Hypertension | 160 (37.9) |
| Hyperlipidemia | 108 (25.5) |
| Cardiovascular disease | 30 (7.1) |
| Fatty liver disease | 60 (14.2) |
| Sleep apnea | 35 (8.2) |
| Asthma | 58 (13.7) |
| Cholelithiasis | 18 (4.2) |
| Joint problems | 85 (20.1) |
| Depression | 61 (14.4) |
| Cancer | 5 (1.1) |
| PCOS | 17 (4.2) |
| Sterility | 3 (0.7) |
| GER | 47 (11.1) |
| Varicose veins | 34 (8.5) |
| BMI before pandemic, kg/m2 | 36.8±7.9 |
| BMI during pandemic, kg/m2 | 36.6±7.9 |
| IPAQ (average MET) | 633.5±1,169.6 |
| MET category, n (%) | |
| Low | 304 (72.0) |
| Moderate | 84 (19.9) |
| High | 34 (8.1) |
| PHQ-9 (total score) | 7.7±5.9 |
| PHQ-9 category, n (%) | |
| <10 | 302 (71.6) |
| ≥10 | 120 (28.4) |
| GAD-7 (total score) | 5.6±5.1 |
| GAD-7 category, n (%) | |
| <10 | 342 (81.0) |
| ≥10 | 80 (19.0) |
BMI, body mass index; IPAQ, International Physical Activity Questionnaire; MET, metabolic equivalent; PHQ-9, Patient Health Questionnaire; GAD-7, General Anxiety Disorder.